BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 28951561)

  • 21. Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.
    Si X; Zhang X; Hao X; Li Y; Chen Z; Ding Y; Shi H; Bai J; Gao Y; Cheng T; Yang FC; Zhou Y
    Oncotarget; 2016 Nov; 7(47):78095-78109. PubMed ID: 27801668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unlocking adult T-cell leukemia/lymphoma's epigenetic secrets: delving into the mechanism and impact of EZH1/2 inhibition.
    Tavakoli Shirazi P; Bywater MJ
    Immunol Cell Biol; 2024; 102(5):298-301. PubMed ID: 38606590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy.
    Guo J; Russell EG; Darcy R; Cotter TG; McKenna SL; Cahill MR; O'Driscoll CM
    Mol Pharm; 2017 Mar; 14(3):940-952. PubMed ID: 28146632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
    Naldini MM; Casirati G; Barcella M; Rancoita PMV; Cosentino A; Caserta C; Pavesi F; Zonari E; Desantis G; Gilioli D; Carrabba MG; Vago L; Bernardi M; Di Micco R; Di Serio C; Merelli I; Volpin M; Montini E; Ciceri F; Gentner B
    Nat Commun; 2023 Mar; 14(1):1285. PubMed ID: 36890137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells.
    Lee WS; Ye Z; Cheung AMS; Goh YPS; Oh HLJ; Rajarethinam R; Yeo SP; Soh MK; Chan EHL; Tan LK; Tan SY; Chuah C; Chng WJ; Connolly JE; Wang CI
    Mol Cancer Ther; 2021 Sep; 20(9):1702-1712. PubMed ID: 34158344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant WT1 is associated with DNA hypermethylation of PRC2 targets in AML and responds to EZH2 inhibition.
    Sinha S; Thomas D; Yu L; Gentles AJ; Jung N; Corces-Zimmerman MR; Chan SM; Reinisch A; Feinberg AP; Dill DL; Majeti R
    Blood; 2015 Jan; 125(2):316-26. PubMed ID: 25398938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered mesenchymal stem cell exosomes loaded with miR-34c-5p selectively promote eradication of acute myeloid leukemia stem cells.
    Wen J; Chen Y; Liao C; Ma X; Wang M; Li Q; Wang D; Li Y; Zhang X; Li L; Zhou H; Zou J; Liu L; Peng D
    Cancer Lett; 2023 Oct; 575():216407. PubMed ID: 37769796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
    Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipids and the cancer stemness regulatory system in acute myeloid leukemia.
    Lim INX; Nagree MS; Xie SZ
    Essays Biochem; 2022 Sep; 66(4):333-344. PubMed ID: 35996953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GPR84 sustains aberrant β-catenin signaling in leukemic stem cells for maintenance of MLL leukemogenesis.
    Dietrich PA; Yang C; Leung HH; Lynch JR; Gonzales E; Liu B; Haber M; Norris MD; Wang J; Wang JY
    Blood; 2014 Nov; 124(22):3284-94. PubMed ID: 25293777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells.
    Kikushige Y; Miyamoto T
    Int J Hematol; 2013 Dec; 98(6):627-33. PubMed ID: 24046178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Progress in the studies of acute myelogenous leukemia stem cell].
    Cui JW; Zhang XM; Wang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and functional relevance of long non-coding RNAs in acute myeloid leukemia stem cells.
    Bill M; Papaioannou D; Karunasiri M; Kohlschmidt J; Pepe F; Walker CJ; Walker AE; Brannan Z; Pathmanathan A; Zhang X; Mrózek K; LaRocco A; Volinia S; Bloomfield CD; Garzon R; Dorrance AM
    Leukemia; 2019 Sep; 33(9):2169-2182. PubMed ID: 30858548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIM-3 is a promising target to selectively kill acute myeloid leukemia stem cells.
    Kikushige Y; Shima T; Takayanagi S; Urata S; Miyamoto T; Iwasaki H; Takenaka K; Teshima T; Tanaka T; Inagaki Y; Akashi K
    Cell Stem Cell; 2010 Dec; 7(6):708-17. PubMed ID: 21112565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner.
    Mochizuki-Kashio M; Aoyama K; Sashida G; Oshima M; Tomioka T; Muto T; Wang C; Iwama A
    Blood; 2015 Sep; 126(10):1172-83. PubMed ID: 26219303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting acute myeloid leukemia stem cell signaling by natural products.
    Siveen KS; Uddin S; Mohammad RM
    Mol Cancer; 2017 Jan; 16(1):13. PubMed ID: 28137265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The methyltransferases enhancer of zeste homolog (EZH) 1 and EZH2 control hepatocyte homeostasis and regeneration.
    Bae WK; Kang K; Yu JH; Yoo KH; Factor VM; Kaji K; Matter M; Thorgeirsson S; Hennighausen L
    FASEB J; 2015 May; 29(5):1653-62. PubMed ID: 25477280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-MPL Is a Candidate Surface Marker and Confers Self-Renewal, Quiescence, Chemotherapy Resistance, and Leukemia Initiation Potential in Leukemia Stem Cells.
    Li H; Zhao N; Li Y; Xing H; Chen S; Xu Y; Tang K; Tian Z; Wang M; Rao Q; Wang J
    Stem Cells; 2018 Nov; 36(11):1685-1696. PubMed ID: 30106501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Enhancer of Zeste Homolog 2 (EZH2) Gene in Acute Myeloid Leukemia.
    Hamed NAM; El Ghandour A; Abo Elwafa RA; Rezk MR; Ghallab O
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):81-85. PubMed ID: 36708555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.
    Dorrance AM; Neviani P; Ferenchak GJ; Huang X; Nicolet D; Maharry KS; Ozer HG; Hoellarbauer P; Khalife J; Hill EB; Yadav M; Bolon BN; Lee RJ; Lee LJ; Croce CM; Garzon R; Caligiuri MA; Bloomfield CD; Marcucci G
    Leukemia; 2015 Nov; 29(11):2143-53. PubMed ID: 26055302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.